Ad
related to: abraxane
Search results
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib
Zacks via Yahoo Finance· 2 years agoPuma Biotechnology (PBYI) inks license agreement with Japan's Takeda Pharmaceuticals, gaining...
The Generics Are Here: How Bristol Myers Squibb Expects Patent Losses To Hit In 2022
Investor's Business Daily· 2 years agoBristol Myers Squibb reaffirmed expectations for a $10 billion pitfall from its generics-facing...
Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 2 months agoEvaluate the expected performance of Bristol Myers (BMY) for the quarter ended March 2024, looking...
Compared to Estimates, Bristol Myers (BMY) Q4 Earnings: A Look at Key Metrics
Zacks via Yahoo Finance· 5 months agoWhile the top- and bottom-line numbers for Bristol Myers (BMY) give a sense of how the business...
Syros (SYRS) Up on FDA's Orphan Tag for Pancreatic Cancer Drug
Zacks via Yahoo Finance· 2 years agoSyros Pharmaceuticals (SYRS) receives Orphan Drug designation from the FDA for its pipeline...
3 No-Brainer Stocks to Buy With $500 Right Now
Motley Fool· 7 months agoOver the long run, Wall Street is a playground that allows optimists to profit handsomely. But over shorter timelines, the stock market is an...
Merck Reverses Higher As Keytruda, Gardasil Outplay Covid Decline; Bristol Shares Dip
Investor's Business Daily· 1 year agoMerck topped Wall Street's first-quarter forecasts Thursday while Bristol Myers Squibb delivered a...
Ipsen drug approved by FDA for early pancreatic cancer
BioPharma Dive via Yahoo Finance· 4 months agoDive Brief: The Food and Drug Administration has approved a new regimen for pancreatic cancer,...
Agenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 month agoAgenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript May 7, 2024 Agenus Inc. beats earnings...
2 Top Stocks to Buy In September and Hold Forever
Motley Fool· 2 years agoOne of the world's top biotech businesses, Bristol Myers Squibb (NYSE: BMY), is in the spotlight right now for defying the bear market. As a result,...
